Not yet launched
We haven't launched yet.
But if you have the secret code, come on in.
Your VCPs are set.
Most PE firms lose value
in the execution.
Your operating partners know which levers to pull. The hard part — and where most holding-period value is lost — is turning those Value Creation Programs into a disciplined portfolio of sub-experiments: sized, governed, and tracked from hypothesis to close.
From VCP to sub-experiment — every step has a governance gate. Every transition gets logged.
The execution gap
You have the VCPs.
Execution is where value leaks.
These aren't process gaps. They're structural — and they compound over a 3–6 year holding period.
"Execution resources spread too thin."
Under each VCP, OPs are running 15–20 sub-experiments simultaneously — at a fraction of the commitment each one needs. Without a prioritization system, effort spreads thin instead of concentrating on the 3–4 that can actually compound to target.
"Approved initiatives stall silently."
A sub-experiment gets approved in the governance meeting. Three months later, nobody can say where it is, who owns it, or why it hasn't moved. The audit trail is a chain of emails.
"No real-time view of what's actually moving."
GPs review decks finalized two weeks ago. There's no live view of which sub-experiments are in flight, which are blocked, and which were quietly deprioritized after the last board call.
"Bad ideas don't die fast enough."
Without structured gates, weak sub-experiments linger. Nobody wants to formally kill someone's initiative. Resources spread thin across half-committed work instead of concentrating on the 3–4 that can compound.
"Pipeline coverage is invisible."
Are we running enough sub-experiments to hit the EBITDA target? You know intuitively it's a numbers game — but there's no system to answer that question across your portfolio companies.
"Execution knowledge walks out with the OP."
No shared framework for how sub-experiments are identified, sized, approved, and tracked. When the OP rotates out, the institutional knowledge goes with them. The next OP starts from scratch.
The execution gap
The VCPs were right.
The execution system wasn't.
Your VCPs came out of due diligence. The strategic direction is correct — inventory optimization, pricing discipline, org efficiency, revenue growth. That thinking was right.
The failure mode is what happens underneath each VCP over the next 3–6 years. Out of 15–20 possible sub-experiments, which 3 get prioritized and fully executed? Which ones stall because the data wasn't ready? Which ones were never formally killed — they just stopped being mentioned?
The EBITDA Expansion Lab is the execution layer your VCPs have been missing — the system that turns strategic priorities into a governed portfolio of sub-experiments, tracked from hypothesis to close.
Suresh Dalai
· Inloop.Studio
Start with proven execution playbooks
You don't have to start from scratch. These sub-experiment templates come from someone who has run these programs — repeatedly, across real portfolio companies.
Markdown Cadence Optimization
100-300 basis points improvement in gross margin
Current markdowns are reactive (end-of-season fire sales) rather than proactive (weekly cadence-driven). Implementing a structured markdown cadence — weekly ...
by Suresh Dalai
Inventory Carrying Cost Reduction
Reducing from 12 months to 5 months = 58% reduction in carrying costs
Current months-of-inventory on hand is [X] months (inventory turns: [Y]). Industry benchmark for this category is [Z] months. Reducing months-on-hand from [X...
by Suresh Dalai
Seasonal Sell-Through Acceleration
Improving sell-through from 40% to 60% = 15-25% reduction in markdown losses
Current seasonal sell-through rate is [X]% vs. industry benchmark of 60%+. By implementing weekly sell-through monitoring and proactive markdown triggers, th...
by Suresh Dalai
These are starting points, not mandates. Every field is editable — the OP customises the template to the specific portfolio company's context.
The lifecycle
From VCP to executed sub-experiment — every step governed, every outcome recorded.
Your VCPs are defined. Break each one into specific, sized sub-experiments. Each follows the same lifecycle — from initial signal to fully qualified investment case to execution and close.
Finding the right sub-experiments.
Under each VCP, there are 15–20 possible paths. The OP has to identify which 3–4 are actually worth pursuing. Without structure, this takes weeks — dominated by data collection and stakeholder interviews that never converge.
Building a crisp, sized hypothesis.
What do we believe is true about this opportunity, and why? Forming a specific, sized hypothesis is the hardest cognitive step. Most sub-experiments stall here — soft observations that never sharpen into a testable investment case.
Sizing the prize for governance.
Expected EBITDA impact quantified. Implementation cost and time horizon documented. Evidence assembled. This is where under-resourced OPs run out of bandwidth before governance even gets to review.
From VCP signal to investment case in 5 days.
The reason most sub-experiments stall before governance is bandwidth. OPs are good at identifying signals — they don't have the time to turn every signal into a crisp, sized, evidence-backed investment case while also running four other portfolio companies.
inloop.studio runs time-boxed Human+AI engagements — each exactly 5 days — designed specifically to take a sub-experiment from raw VCP signal to a governance-ready investment case. The AI accelerates data synthesis and stress-testing. The human brings domain judgment. Together, what takes a solo OP five weeks gets done in a week.
One inloop engagement
Data synthesis & sub-experiment scoping
→ Right 3–4 identified
Hypothesis sharpening & stress-test
→ Crisp case formed
Impact sizing & governance package
→ Ready for approval
Run multiple engagements in parallel across sub-experiments. Each one independent. Each one time-boxed. No open-ended analysis cycles.
Separation of duties enforced.
Only the GP — never the OP who built the case — can approve a sub-experiment. The machine enforces this. Resources are allocated. The clock starts.
Accountability without a meeting.
Tasks track every data request, system access, and stakeholder dependency. Blocking tasks surface automatically on the GP dashboard. Stale sub-experiments trigger alerts before they become problems.
The real number gets recorded.
Actual EBITDA impact vs. expected. Lessons learned. Portfolio metrics update automatically. Successful sub-experiments become execution playbooks for the next engagement.
Three roles. One system.
Built for how PE value creation actually works.
Everyone sees exactly what they need to execute their part. Nothing they shouldn't.
Operating Partners
Break your VCPs into discrete, trackable sub-experiments. Your "burning platform" deck becomes a live portfolio. Advance each sub-experiment through the lifecycle, assign tasks to the client team, and track every blocker in one place.
- Break VCPs into specific, sized sub-experiments
- Work from a library of proven execution playbooks
- Invite collaborators and delegate task ownership
- Present a live sub-experiment pipeline, not a static deck
GPs & Governance Boards
Maintain visibility across VCP execution without getting buried in detail. See pipeline value, success rates, and stalled sub-experiments across all portfolio companies — in one cross-portfolio dashboard.
- Approve sub-experiments — never build them yourself
- Cross-portfolio VCP execution coverage at a glance
- Stale sub-experiment alerts before they compound
- Expected vs. realized EBITDA impact over the hold
Company Staff
Execute the work without seeing the strategy. A scoped task inbox shows exactly what you've been asked to deliver and enough context to understand why — nothing more.
- Personal task inbox scoped to assigned work only
- One-paragraph context per task — no financial detail
- Simple status updates: pending → in progress → done
- No access to pipeline value, strategy, or other sub-experiments
Clarity
What this is not.
The most useful thing we can tell you is what we've chosen not to be.
It does not diagnose your business, identify the right VCPs, or substitute for an operating partner's domain expertise. It assumes the strategic direction is already set. It makes sure that when you execute, nothing falls through the cracks.
It does not ingest your ERP data, run sell-through analysis, or produce charts. That's the consultant's workflow. The EBITDA Expansion Lab is the governance layer that sits on top of that analysis — tracking sub-experiments from hypothesis to outcome.
There are no subtasks, Gantt charts, or sprint boards. A sub-experiment is a hypothesis with a lifecycle — the task checklist tracks data requests and dependencies, not the primary structure. If the team needs full PM capabilities, they should use their existing tools.
There is no automated analysis, no AI-generated hypotheses. The operating partner's expertise is irreplaceable — this system structures and governs their work, it doesn't do it for them. The AI is implicit — not a feature you invoke, but the way the inloop engagement runs.
The structured system that ensures your sub-experiments get run, weak ones get killed early, and the ones that matter don't stall because someone in finance hasn't delivered the data yet.
You have the VCPs.
Now execute them with discipline.
Break each Value Creation Program into specific sub-experiments. Run enough. Kill the weak ones fast. The winners will reveal themselves.
The hard part isn't the strategy — it's making sure nothing falls through the cracks during execution.
Or let's assess your VCP execution discipline →
No setup fee. No demo required. Start with your VCPs and a few sub-experiments.